Substance-Related Disorders  >>  memantine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
MM opioid, NCT01189214: Psychopharmacotherapy in Multiple Substances Abuse

Completed
3
200
RoW
Memantine
National Cheng-Kung University Hospital, National Institutes of Health (NIH)
Substance Abuse
02/11
06/11
NAMHS, NCT00476242: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence

Completed
2/3
82
US
Vivitrol, intramuscular injection of Vivitrol 380 mg, memantine
New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA)
Opioid Dependence, Heroin Dependence
08/11
08/11

Download Options